Fortis Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-55
Closed -$4.43K – 182
2023
Q1
$4.43K Hold
55
– – ﹤0.01% 224
2022
Q4
$4.28K Hold
55
– – ﹤0.01% 222
2022
Q3
$4K Hold
55
– – ﹤0.01% 218
2022
Q2
$5K Hold
55
– – ﹤0.01% 240
2022
Q1
$6K Hold
55
– – ﹤0.01% 249
2021
Q4
$6K Hold
55
– – ﹤0.01% 231
2021
Q3
$7K Hold
55
– – ﹤0.01% 231
2021
Q2
$7K Hold
55
– – ﹤0.01% 234
2021
Q1
$6K Hold
55
– – ﹤0.01% 207
2020
Q4
$6K Buy
+55
New +$6.05K 0.01% 162
2020
Q2
– Sell
-354
Closed -$32K – 262
2020
Q1
$32K Sell
354
-100
-22% -$10.6K 0.02% 206
2019
Q4
$52K Buy
454
+146
+47% +$16K 0.03% 208
2019
Q3
$35K Hold
308
– – 0.02% 224
2019
Q2
$30K Hold
308
– – 0.01% 266
2019
Q1
$28K Hold
308
– – 0.01% 254
2018
Q4
$28K Hold
308
– – 0.02% 249
2018
Q3
$30K Sell
308
-50
-14% -$4.62K 0.02% 227
2018
Q2
$32K Hold
358
– – 0.02% 228
2018
Q1
$29K Hold
358
– – 0.02% 195
2017
Q4
$29K Sell
358
-50
-12% -$4K 0.02% 197
2017
Q3
$32K Buy
408
+208
+104% +$17.3K 0.02% 182
2017
Q2
$18K Hold
200
– – 0.01% 80
2017
Q1
$16K Buy
+200
New +$15.6K 0.01% 72

Other funds holding MDT

Fortis Advisors's MDT Position: Q2 2023 in Review

Fortis Advisors sold out of Medtronic (MDT) in Q2 2023, closing a stake of 55 shares — an estimated $4.43K sold.

Fortis Advisors first reported a position in MDT in Q1 2017 and held it in 23 quarters. The position peaked at $52K in Q4 2019. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Fortis Advisors reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Fortis Advisors sold 55 Medtronic shares in Q2 2023, an estimated $4.43K.
  • Fortis Advisors first reported a position in Medtronic in Q1 2017 and held it in 23 quarters.
  • Fortis Advisors's Medtronic position peaked at $52K in Q4 2019.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Fortis Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.